Search our stories, awards, events and funding

Translational immunology

Autoimmunity

Immune deficiency

Infectious disease immunology

Tumor immunology

Cancer, autoimmune diseases, infectious diseases, and immunodeficiencies (primary or acquired) are prevalent disorders in developed countries, and they are also the leading causes of morbidity and mortality in Hong Kong and many other countries in this region. These conditions are underpinned by dysregulated immune reactions, highlighting the importance of rebalancing the immune response as a pivotal element in disease management and curative treatment. While researchers in Hong Kong have made significant strides in characterising the clinical presentation and outcomes of these conditions, translational immunology research in these areas is still in its infancy.

1. To provide the opportunities for postgraduate research students, early postdocs and junior clinical scientists to learn about the latest bench-to-bedside advances in immunology.

2. To promote interactive communication between junior researchers and leading experts in immunology in order to foster excellence in immunology research and teaching in Hong Kong

15 July — 19 July 2024
University of Hong Kong
HK$3,000 (Includes accommodation)
Apply by 30 April 2024
Fully booked

Past

What you'll study

You will learn about the latest advances in cancer immunology, autoimmunity, infection and immunity, as well as immunodeficiencies from world leaders in the field.

Who is the course for

Postgraduate research students, early postdocs and junior clinical scientists

If you have any enquiries about the course, please contact Gladys Chu by email at gladys@talent-links.com.